Which
might benefit from bullish ratings?
How could
react to new therapies?
What other
may follow Weyerhaeuser?
Will
gain from VolitionRx’s growth?
How might
be impacted by Sun Communities?
Which
could see growth with Spyre’s performance?
Could
influence the ophthalmology market?
What trends might affect
for small caps?
How will
to these bullish calls?
Which
are at risk from potential downgrades?
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
|
date ▲▼ |
ticker ▲▼ |
name ▲▼ |
Price Target ▲▼ |
Upside/Downside ▲▼ |
Recommendation ▲▼ |
Firm ▲▼ |
|---|
Analyst Calendar
Join Benzinga Edge and unlock all the major upgrades, downgrades, and changes to the market’s most accurate analysts.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
